The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.
Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD
The neurology market is again attracting attention and investment from various — and at times unexpected — corners of the biopharma industry.
The organization said it used Facebook to identify participants for a study designed to identify biomarkers associated with Parkinson's disease.
Drugmakers and tech companies are developing wearables and using popular fitness trackers like the Fitbit in clinical trials to gain insights about Parkinson's Disease.